Venture
Affiliations
Yale University
Technologies
Therapeutic
Indication
Basic Research
Clinical Research
Clinical Trials
Neurodegenerative Disease
Oncology
Website
epigenomax.comEpigenoMax Therapeutics is a startup biotech company focusing on the development of bioactive targeting drugs, “Precision Molecular Surgery Knife” for treatments of late-stage colorectal cancer.
EpigenoMax Therapeutics Team: